Ulcerative colitis: open trials in Australia

17 open trials have a site in Australia. Registry data; only the trial team decides who can take part.

NCT07158242
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Hoffmann-La Roche
Perth Children's Hospital, Nedlands · Royal Childrens Hospital, Parkville · Mater Hospital Brisbane, South Brisbane
Registry updated 2026-11-05
NCT07916727
Specific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO Study
Trial Treatment · Austin Health
Royal Hobart Hospital, Hobart · Eastern Health, Melbourne · Austin Health, Melbourne · Mercy Health, Melbourne · Peninsula Health, Melbourne · St Vincent's Hospital Darlinghurst, Sydney · Royal Prince Alfred Hospital, Sydney
Registry updated 2026-11-04
NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
The Kids Research Institute Australia on behalf of the Centre for Child Health Research, Nedlands · Mater Hospital Brisbane Inflammatory Bowel Diseases, South Brisbane · The Children's Hospital at Westmead, Westmead
Registry updated 2026-11-03
NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Banksia Trials SA, Adelaide · Royal Prince Alfred Hospital, Camperdown · Monash Medical Centre, Clayton · SA Gastrointestinal Services, Kurraba Point · Macquarie University, Macquarie Island · Fiona Stanley Hospital, Murdoch · John Hunter Hospital, New Lambton · Mater Misericordiae Hospital, South Brisbane · The Melbourne Gut Clinic Epworth Hospital, West Melbourne
Registry updated 2026-11-03
NCT07652294
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Concord · South Brisbane
Registry updated 2026-11-03
NCT06619990
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Trial Treatment · Phase 1/2 · Xencor, Inc.
Adelaide · Brisbane · Joondalup · Macquarie Park · Melbourne · Nedlands · South Brisbane · Southport · Wollongong
Registry updated 2026-10-30
NCT06979336
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Trial Treatment · Phase 2 · Genentech, Inc.
Royal Prince Alfred Hospital, Camperdown · Fiona Stanley Hospital, Murdoch · Royal Melbourne Hospital, Parkville VIC · Mater Misericordiae Limited, South Brisbane
Registry updated 2026-10-27
NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Concord · Heidelberg · Liverpool · Melbourne · Murdoch · South Brisbane · Woolloongabba
Registry updated 2026-10-27
NCT07470879
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Trial Treatment · Phase 2 · Pfizer
Queensland Children's Hospital, Brisbane · Monash Health, Clayton · Perth Children's Hospital, Perth · The Children's Hospital at Westmead, Westmead
Registry updated 2026-10-26
NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Liverpool · Wollongong
Registry updated 2026-10-23
NCT05076175
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Monash Health, Clayton · Murdoch · Nedlands · The Children's Hospital at Westmead, Westmead
Registry updated 2026-10-20
NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
South Brisbane
Registry updated 2026-10-16
NCT07869225
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study of EQ504 in Single and Multiple Ascending Doses in Healthy Volunteers
Trial Treatment · Phase 1 · Equillium
Veritus Research, Melbourne
Registry updated 2026-10-09
NCT07505030
To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of LYNC-101 for Injection in Healthy Adult Participants
Trial Treatment · Phase 1 · LyncBio Therapeutics Co., Ltd.
CMAX Clinical Research Pty Ltd, Adelaide
Registry updated 2026-08-27
NCT07526519
A Safety and Pharmacokinetics Study of TL-003 in Healthy Adults and Open-label Assessments in Participants With Ulcerative Colitis
Trial Treatment · Phase 1 · TrueLab Biopharmaceutical Co., Ltd
Linear Early Phase Ltd, Perth
Registry updated 2026-05-15
NCT05442567
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Monash Health (Monash Medical Centre), Clayton · Royal Children's Hospital Melbourne - PIN, Parkville · Queensland Childrens Hospital, South Brisbane · Children's Hospital at Westmead, Westmead
Registry updated 2026-05-07
NCT06850727
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Odyssey Therapeutics, Inc.
Sunshine Coast University, Birtinya · Eastern Health, Box Hill · Coastal Digestive Health, Maroochydore · Alfred Health, Melbourne · Fiona Stanley Hospital, Murdoch · Royal Melbourne Hospital, Parkville
Registry updated 2026-02-11

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error